BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 388208 NCCCCN(Cc1nccc2c1[nH]c1ccccc21)C1CCCc2cccnc12 221714 US9314468, Table 7, Compound 1 C-X-C chemokine receptor type 4 Human 142 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221714&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 44242663 335960672 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388209 Cn1c(CN(CCCCN)C2CCCc3cccnc23)nnc1-c1ccccc1 InChI=1S/C23H30N6/c1-28-21(26-27-23(28)19-9-3-2-4-10-19)17-29(16-6-5-14-24)20-13-7-11-18-12-8-15-25-22(18)20/h2-4,8-10,12,15,20H,5-7,11,13-14,16-17,24H2,1H3 IQXADRSWBMCYJU-UHFFFAOYSA-N 221715 US9314468, Table 7, Compound 2 C-X-C chemokine receptor type 4 Human 3200 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221715&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 44242331 335960673 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388210 C(CCN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12)CNC1=NCCN1 221716 US9314468, Table 7, Compound 3 C-X-C chemokine receptor type 4 Human 1666 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221716&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 44242735 335960674 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388211 C(CCN(Cc1nccc2c1[nH]c1ccccc21)C1CCCc2cccnc12)CNCc1ccccn1 221717 US9314468, Table 7, Compound 4 C-X-C chemokine receptor type 4 Human 5100 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221717&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70923310 335960675 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388212 NCCCCN(Cc1nccc2c3ccc(F)cc3[nH]c12)C1CCCc2cccnc12 221725 US9314468, Table 7, Compound 12 C-X-C chemokine receptor type 4 Human 565 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221725&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924218 335960676 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388213 C(CCN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12)CNCC1CC1 221727 US9314468, Table 7, Compound 14 C-X-C chemokine receptor type 4 Human 729 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221727&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924138 335960677 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388214 CCNCCCCN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12 221728 US9314468, Table 7, Compound 15 C-X-C chemokine receptor type 4 Human 168 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221728&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924220 335960678 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388215 CN(C)C(=O)NCCCCN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12 221729 US9314468, Table 7, Compound 16 C-X-C chemokine receptor type 4 Human 38 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221729&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924219 335960679 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388216 CC(=O)NCCCCN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12 221730 US9314468, Table 7, Compound 17 C-X-C chemokine receptor type 4 Human 1720 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221730&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924231 335960680 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388217 CS(=O)(=O)N1CCN(CCN(Cc2nccc3c4ccccc4[nH]c23)C2CCCc3cccnc23)CC1 221736 US9314468, Table 7, Compound 23 C-X-C chemokine receptor type 4 Human 9999 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221736&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924194 335960681 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388218 NCCCCN(Cc1cc2c(cn1)[nH]c1ccccc21)C1CCCc2cccnc12 221737 US9314468, Table 7, Compound 24 C-X-C chemokine receptor type 4 Human 69 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221737&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176482 335960682 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388219 Cn1c2ccccc2c2ccnc(CN(CCCCN)C3CCCc4cccnc34)c12 InChI=1S/C26H31N5/c1-30-23-11-3-2-10-20(23)21-13-16-28-22(26(21)30)18-31(17-5-4-14-27)24-12-6-8-19-9-7-15-29-25(19)24/h2-3,7,9-11,13,15-16,24H,4-6,8,12,14,17-18,27H2,1H3 WMXHNYCIMIWIHK-UHFFFAOYSA-N 221738 US9314468, Table 7, Compound 25 C-X-C chemokine receptor type 4 Human 10 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221738&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176527 335960683 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388220 C(CN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12)CN1CCNCC1 221740 US9314468, Table 7, Compound 27 C-X-C chemokine receptor type 4 Human 18 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221740&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70923321 335960684 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388221 CC(C)(C)C(=O)N1CCN(CCCN(Cc2nccc3c4ccccc4[nH]c23)C2CCCc3cccnc23)CC1 221741 US9314468, Table 7, Compound 28 C-X-C chemokine receptor type 4 Human 1930 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221741&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924193 335960685 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388222 C(CCN1CCNCC1)CN(Cc1nccc2c3ccccc3[nH]c12)C1CCCc2cccnc12 221743 US9314468, Table 7, Compound 30 C-X-C chemokine receptor type 4 Human 1955 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221743&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924201 335960686 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388223 Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C26H31N5/c1-30-23-11-3-2-10-20(23)21-13-16-28-22(26(21)30)18-31(17-5-4-14-27)24-12-6-8-19-9-7-15-29-25(19)24/h2-3,7,9-11,13,15-16,24H,4-6,8,12,14,17-18,27H2,1H3/t24-/m0/s1 WMXHNYCIMIWIHK-DEOSSOPVSA-N 221744 US9314468, Table 7, Compound 31 C-X-C chemokine receptor type 4 Human 22 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221744&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176638 335960687 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388224 CCNCCCCN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12 221745 US9314468, Table 7, Compound 32 C-X-C chemokine receptor type 4 Human 699 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221745&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924166 335960688 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388225 C(CCN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12)CNCC1CC1 221747 US9314468, Table 7, Compound 34 C-X-C chemokine receptor type 4 Human 451 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221747&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924169 335960689 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388226 C(CN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12)CN1CCNCC1 221752 US9314468, Table 7, Compound 39 C-X-C chemokine receptor type 4 Human 87 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221752&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924205 335960690 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388227 NCCCCN(Cc1nccc2c1[nH]c1ccccc21)[C@H]1CCCc2cccnc12 221755 US9314468, Table 7, Compound 42 C-X-C chemokine receptor type 4 Human 30 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221755&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924213 335960691 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388228 NCCCCN(Cc1nccc2c1[nH]c1ccccc21)[C@@H]1CCCc2cccnc12 221756 US9314468, Table 7, Compound 43 C-X-C chemokine receptor type 4 Human 1340 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221756&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924203 335960692 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388229 NCCCCN(Cc1cc2c(cn1)[nH]c1ccccc21)[C@@H]1CCCc2cccnc12 221757 US9314468, Table 7, Compound 44 C-X-C chemokine receptor type 4 Human 1180 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221757&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176619 335960693 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388230 NCCCCN(Cc1cc2c(cn1)[nH]c1ccccc21)[C@H]1CCCc2cccnc12 221758 US9314468, Table 7, Compound 45 C-X-C chemokine receptor type 4 Human 100 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221758&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176443 335960694 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388231 CC(C)(C)OC(=O)Cn1c2ccccc2c2ccnc(CN[C@H]3CCCc4cccnc34)c12 InChI=1S/C27H30N4O2/c1-27(2,3)33-24(32)17-31-23-12-5-4-10-19(23)20-13-15-28-22(26(20)31)16-30-21-11-6-8-18-9-7-14-29-25(18)21/h4-5,7,9-10,12-15,21,30H,6,8,11,16-17H2,1-3H3/t21-/m0/s1 PKCQUNGFEWNMCR-NRFANRHFSA-N 221759 US9314468, Table 7, Compound 46 C-X-C chemokine receptor type 4 Human 2810 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221759&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176563 335960695 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388232 CC(C)(C)OC(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C31H39N5O2/c1-31(2,3)38-28(37)21-36-26-13-5-4-12-23(26)24-15-18-33-25(30(24)36)20-35(19-7-6-16-32)27-14-8-10-22-11-9-17-34-29(22)27/h4-5,9,11-13,15,17-18,27H,6-8,10,14,16,19-21,32H2,1-3H3/t27-/m0/s1 DMDKSTXUAWRNLR-MHZLTWQESA-N 221760 US9314468, Table 7, Compound 47 C-X-C chemokine receptor type 4 Human 1 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221760&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 44470245 335960696 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388233 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCOCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H38N6O2/c32-13-3-4-16-36(28-11-5-7-23-8-6-14-34-30(23)28)21-26-31-25(12-15-33-26)24-9-1-2-10-27(24)37(31)22-29(38)35-17-19-39-20-18-35/h1-2,6,8-10,12,14-15,28H,3-5,7,11,13,16-22,32H2/t28-/m0/s1 PBOCFANSMNVTHY-NDEPHWFRSA-N 221761 US9314468, Table 7, Compound 48::US9314468, Table 9, Compound 1 C-X-C chemokine receptor type 4 Human 79 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221761&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176381 335960697 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388234 NCCCCN(Cc1ccccn1)Cc1nccc2c3ccccc3[nH]c12 InChI=1S/C22H25N5/c23-11-4-6-14-27(15-17-7-3-5-12-24-17)16-21-22-19(10-13-25-21)18-8-1-2-9-20(18)26-22/h1-3,5,7-10,12-13,26H,4,6,11,14-16,23H2 JPODKGBHEFBGOW-UHFFFAOYSA-N 221762 US9314468, Table 7, Compound 49 C-X-C chemokine receptor type 4 Human 1970 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221762&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 44241788 335960698 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388235 Cn1c2ccccc2c2cc(CN(CCCCN)[C@H]3CCCc4cccnc34)ncc12 InChI=1S/C26H31N5/c1-30-23-11-3-2-10-21(23)22-16-20(29-17-25(22)30)18-31(15-5-4-13-27)24-12-6-8-19-9-7-14-28-26(19)24/h2-3,7,9-11,14,16-17,24H,4-6,8,12-13,15,18,27H2,1H3/t24-/m0/s1 FLQIPSJEOPVBPV-DEOSSOPVSA-N 221763 US9314468, Table 7, Compound 50 C-X-C chemokine receptor type 4 Human 57 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221763&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176510 335960699 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388236 C(CN(Cc1cc2c(cn1)[nH]c1ccccc21)[C@H]1CCCc2cccnc12)CN1CCNCC1 221766 US9314468, Table 7, Compound 53 C-X-C chemokine receptor type 4 Human 331 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221766&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176471 335960700 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388237 NCCCCN(Cc1cc2c(cn1)n(CC(O)=O)c1ccccc21)[C@H]1CCCc2cccnc12 InChI=1S/C27H31N5O2/c28-12-3-4-14-31(24-11-5-7-19-8-6-13-29-27(19)24)17-20-15-22-21-9-1-2-10-23(21)32(18-26(33)34)25(22)16-30-20/h1-2,6,8-10,13,15-16,24H,3-5,7,11-12,14,17-18,28H2,(H,33,34)/t24-/m0/s1 REKOGIWNXOWNQZ-DEOSSOPVSA-N 221768 US9314468, Table 7, Compound 55 C-X-C chemokine receptor type 4 Human 864 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221768&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176628 335960701 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388238 NCCCCN(Cc1nccc2c3ccccc3n(CC(O)=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H31N5O2/c28-13-3-4-16-31(24-11-5-7-19-8-6-14-30-26(19)24)17-22-27-21(12-15-29-22)20-9-1-2-10-23(20)32(27)18-25(33)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H,33,34)/t24-/m0/s1 HXSKVZXRXQFNGG-DEOSSOPVSA-N 221769 US9314468, Table 7, Compound 56::US9314468, Table 9, Compound 2 C-X-C chemokine receptor type 4 Human 22 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221769&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176365 335960702 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388239 CC(C)(C)OC(=O)Cn1c2ccccc2c2cc(CN(CCCCN)[C@H]3CCCc4cccnc34)ncc12 InChI=1S/C31H39N5O2/c1-31(2,3)38-29(37)21-36-26-13-5-4-12-24(26)25-18-23(34-19-28(25)36)20-35(17-7-6-15-32)27-14-8-10-22-11-9-16-33-30(22)27/h4-5,9,11-13,16,18-19,27H,6-8,10,14-15,17,20-21,32H2,1-3H3/t27-/m0/s1 AOOHTIPPARZMSX-MHZLTWQESA-N 221771 US9314468, Table 7, Compound 58 C-X-C chemokine receptor type 4 Human 949 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221771&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176632 335960703 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388240 NC(=O)NCCCCN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12 221773 US9314468, Table 7, Compound 60 C-X-C chemokine receptor type 4 Human 6671 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221773&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924077 335960704 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388241 CCOC(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C29H35N5O2/c1-2-36-27(35)20-34-25-12-4-3-11-22(25)23-14-17-31-24(29(23)34)19-33(18-6-5-15-30)26-13-7-9-21-10-8-16-32-28(21)26/h3-4,8,10-12,14,16-17,26H,2,5-7,9,13,15,18-20,30H2,1H3/t26-/m0/s1 VFJCHGDYUBWKFI-SANMLTNESA-N 221775 US9314468, Table 7, Compound 62 C-X-C chemokine receptor type 4 Human 15 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221775&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176542 335960705 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388242 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H39N7O/c32-13-3-4-18-37(28-11-5-7-23-8-6-14-35-30(23)28)21-26-31-25(12-15-34-26)24-9-1-2-10-27(24)38(31)22-29(39)36-19-16-33-17-20-36/h1-2,6,8-10,12,14-15,28,33H,3-5,7,11,13,16-22,32H2/t28-/m0/s1 NJQWIRGYRIYSTI-NDEPHWFRSA-N 221778 US9314468, Table 7, Compound 65 C-X-C chemokine receptor type 4 Human 663 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221778&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924083 335960706 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388243 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)NC3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H41N7O/c33-15-3-4-20-38(29-11-5-7-23-8-6-16-36-31(23)29)21-27-32-26(14-19-35-27)25-9-1-2-10-28(25)39(32)22-30(40)37-24-12-17-34-18-13-24/h1-2,6,8-10,14,16,19,24,29,34H,3-5,7,11-13,15,17-18,20-22,33H2,(H,37,40)/t29-/m0/s1 OIRFPCPZHQDIOS-LJAQVGFWSA-N 221779 US9314468, Table 7, Compound 66 C-X-C chemokine receptor type 4 Human 110 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221779&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176435 335960707 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388244 NC\C=C/CN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12 221781 US9314468, Table 7, Compound 68 C-X-C chemokine receptor type 4 Human 949 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221781&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924239 335960708 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388245 NC(=O)CCCN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12 221782 US9314468, Table 7, Compound 69 C-X-C chemokine receptor type 4 Human 1440 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221782&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924224 335960709 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388246 NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H43N7/c33-14-3-4-20-38(30-12-5-8-25-9-6-15-36-31(25)30)24-28-32-27(13-16-35-28)26-10-1-2-11-29(26)39(32)21-7-19-37-22-17-34-18-23-37/h1-2,6,9-11,13,15-16,30,34H,3-5,7-8,12,14,17-24,33H2/t30-/m0/s1 KRDNCRHWZIFVKV-PMERELPUSA-N 221783 US9314468, Table 7, Compound 70::US9314468, Table 9, Compound 4 C-X-C chemokine receptor type 4 Human 15 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221783&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176504 335960710 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388247 CN1CCN(CC1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C32H41N7O/c1-36-18-20-37(21-19-36)30(40)23-39-28-11-3-2-10-25(28)26-13-16-34-27(32(26)39)22-38(17-5-4-14-33)29-12-6-8-24-9-7-15-35-31(24)29/h2-3,7,9-11,13,15-16,29H,4-6,8,12,14,17-23,33H2,1H3/t29-/m0/s1 JQTHZRINXVEAFM-LJAQVGFWSA-N 221785 US9314468, Table 7, Compound 72::US9314468, Table 9, Compound 5 C-X-C chemokine receptor type 4 Human 30 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221785&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176465 335960711 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388248 CN(Cc1nccc2c3ccccc3n(CCCCN)c12)[C@H]1CCCc2cccnc12 InChI=1S/C26H31N5/c1-30(24-12-6-8-19-9-7-15-29-25(19)24)18-22-26-21(13-16-28-22)20-10-2-3-11-23(20)31(26)17-5-4-14-27/h2-3,7,9-11,13,15-16,24H,4-6,8,12,14,17-18,27H2,1H3/t24-/m0/s1 VBDFJRFDMOITRW-DEOSSOPVSA-N 221786 US9314468, Table 7, Compound 73 C-X-C chemokine receptor type 4 Human 3370 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221786&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176496 335960712 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388249 CN(Cc1nccc2c3ccccc3n(CCCN3C(=O)c4ccccc4C3=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C33H31N5O2/c1-36(29-15-6-9-22-10-7-17-35-30(22)29)21-27-31-24(16-18-34-27)23-11-4-5-14-28(23)37(31)19-8-20-38-32(39)25-12-2-3-13-26(25)33(38)40/h2-5,7,10-14,16-18,29H,6,8-9,15,19-21H2,1H3/t29-/m0/s1 CVOFDCHMJDTJQF-LJAQVGFWSA-N 221787 US9314468, Table 7, Compound 74 C-X-C chemokine receptor type 4 Human 217 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221787&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176576 335960713 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388250 O=C(Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C34H43N7O2/c42-32(39-20-22-43-23-21-39)25-41-30-9-2-1-8-27(30)28-11-13-36-29(34(28)41)24-40(17-5-16-38-18-14-35-15-19-38)31-10-3-6-26-7-4-12-37-33(26)31/h1-2,4,7-9,11-13,31,35H,3,5-6,10,14-25H2/t31-/m0/s1 KHUKENRHVPYVIS-HKBQPEDESA-N 221788 US9314468, Table 7, Compound 75 C-X-C chemokine receptor type 4 Human 44 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221788&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176424 335960714 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388251 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCC(N)CC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H41N7O/c33-15-3-4-18-38(29-11-5-7-23-8-6-16-36-31(23)29)21-27-32-26(12-17-35-27)25-9-1-2-10-28(25)39(32)22-30(40)37-19-13-24(34)14-20-37/h1-2,6,8-10,12,16-17,24,29H,3-5,7,11,13-15,18-22,33-34H2/t29-/m0/s1 SWKZMADSDIUPGO-LJAQVGFWSA-N 221789 US9314468, Table 7, Compound 76 C-X-C chemokine receptor type 4 Human 4390 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221789&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176519 335960715 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388252 CN(Cc1nccc2c3ccccc3n(CCN3C(=O)c4ccccc4C3=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H29N5O2/c1-35(28-14-6-8-21-9-7-16-34-29(21)28)20-26-30-23(15-17-33-26)22-10-4-5-13-27(22)36(30)18-19-37-31(38)24-11-2-3-12-25(24)32(37)39/h2-5,7,9-13,15-17,28H,6,8,14,18-20H2,1H3/t28-/m0/s1 GJIDOKDKTJPHIP-NDEPHWFRSA-N 221790 US9314468, Table 7, Compound 77 C-X-C chemokine receptor type 4 Human 329 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221790&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176593 335960716 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388253 CN(Cc1nccc2c3ccccc3n(CCCN)c12)[C@H]1CCCc2cccnc12 InChI=1S/C25H29N5/c1-29(23-11-4-7-18-8-5-14-28-24(18)23)17-21-25-20(12-15-27-21)19-9-2-3-10-22(19)30(25)16-6-13-26/h2-3,5,8-10,12,14-15,23H,4,6-7,11,13,16-17,26H2,1H3/t23-/m0/s1 JHTFMCRYSBBHJA-QHCPKHFHSA-N 221791 US9314468, Table 7, Compound 78 C-X-C chemokine receptor type 4 Human 1046 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221791&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176363 335960717 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388254 CN(Cc1nccc2c3ccccc3n(CCN)c12)[C@H]1CCCc2cccnc12 InChI=1S/C24H27N5/c1-28(22-10-4-6-17-7-5-13-27-23(17)22)16-20-24-19(11-14-26-20)18-8-2-3-9-21(18)29(24)15-12-25/h2-3,5,7-9,11,13-14,22H,4,6,10,12,15-16,25H2,1H3/t22-/m0/s1 YPIBGKBPCMCEEX-QFIPXVFZSA-N 221792 US9314468, Table 7, Compound 79 C-X-C chemokine receptor type 4 Human 142 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221792&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176474 335960718 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388255 NCCCCN(Cc1nccc2c3ccccc3n(CC#C)c12)[C@H]1CCCc2cccnc12 InChI=1S/C28H31N5/c1-2-18-33-25-12-4-3-11-22(25)23-14-17-30-24(28(23)33)20-32(19-6-5-15-29)26-13-7-9-21-10-8-16-31-27(21)26/h1,3-4,8,10-12,14,16-17,26H,5-7,9,13,15,18-20,29H2/t26-/m0/s1 LWLCPNMLRWYQTO-SANMLTNESA-N 221793 US9314468, Table 7, Compound 80 C-X-C chemokine receptor type 4 Human 9 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221793&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176556 335960719 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388256 O=C(CN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12)N1CCNCC1 221794 US9314468, Table 7, Compound 81 C-X-C chemokine receptor type 4 Human 1810 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221794&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924214 335960720 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388257 NCCCCN(Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H40N6O/c32-13-3-4-16-36(29-11-5-7-24-8-6-14-34-30(24)29)23-27-31-26(12-15-33-27)25-9-1-2-10-28(25)37(31)18-17-35-19-21-38-22-20-35/h1-2,6,8-10,12,14-15,29H,3-5,7,11,13,16-23,32H2/t29-/m0/s1 CVDHYOXZYVHTOU-LJAQVGFWSA-N 221796 US9314468, Table 7, Compound 83 C-X-C chemokine receptor type 4 Human 4 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221796&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176372 335960721 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388258 NCCCn1c2ccccc2c2ccnc(CN[C@H]3CCCc4cccnc34)c12 InChI=1S/C24H27N5/c25-12-5-15-29-22-10-2-1-8-18(22)19-11-14-26-21(24(19)29)16-28-20-9-3-6-17-7-4-13-27-23(17)20/h1-2,4,7-8,10-11,13-14,20,28H,3,5-6,9,12,15-16,25H2/t20-/m0/s1 ANEBBEKYLUMKMR-FQEVSTJZSA-N 221799 US9314468, Table 7, Compound 86 C-X-C chemokine receptor type 4 Human 8890 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221799&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176531 335960722 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388259 NCCCCN(Cc1nccc2c3ccccc3n(CCO)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H33N5O/c28-13-3-4-16-31(25-11-5-7-20-8-6-14-30-26(20)25)19-23-27-22(12-15-29-23)21-9-1-2-10-24(21)32(27)17-18-33/h1-2,6,8-10,12,14-15,25,33H,3-5,7,11,13,16-19,28H2/t25-/m0/s1 YPUCQUYXFQEHNX-VWLOTQADSA-N 221800 US9314468, Table 7, Compound 87 C-X-C chemokine receptor type 4 Human 11 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221800&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176432 335960723 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388260 NCCCCN(Cc1nccc2c3ccccc3n(Cc3ccccn3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H34N6/c32-16-4-6-20-36(29-14-7-9-23-10-8-18-35-30(23)29)22-27-31-26(15-19-34-27)25-12-1-2-13-28(25)37(31)21-24-11-3-5-17-33-24/h1-3,5,8,10-13,15,17-19,29H,4,6-7,9,14,16,20-22,32H2/t29-/m0/s1 MSCRAFSZHJSLOE-LJAQVGFWSA-N 221801 US9314468, Table 7, Compound 88 C-X-C chemokine receptor type 4 Human 31 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221801&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176389 335960724 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388261 CCN(Cc1nccc2c3ccccc3n(CCCN3C(=O)c4ccccc4C3=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C34H33N5O2/c1-2-37(30-16-7-10-23-11-8-18-36-31(23)30)22-28-32-25(17-19-35-28)24-12-5-6-15-29(24)38(32)20-9-21-39-33(40)26-13-3-4-14-27(26)34(39)41/h3-6,8,11-15,17-19,30H,2,7,9-10,16,20-22H2,1H3/t30-/m0/s1 KHGMLCBVTVUVMO-PMERELPUSA-N 221802 US9314468, Table 7, Compound 89 C-X-C chemokine receptor type 4 Human 1640 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221802&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176526 335960725 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388262 CC(C)(C)OC(=O)Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C34H44N6O2/c1-34(2,3)42-31(41)24-40-29-12-5-4-11-26(29)27-14-16-36-28(33(27)40)23-39(20-8-19-38-21-17-35-18-22-38)30-13-6-9-25-10-7-15-37-32(25)30/h4-5,7,10-12,14-16,30,35H,6,8-9,13,17-24H2,1-3H3/t30-/m0/s1 AQKCUDVGYZOCIQ-PMERELPUSA-N 221803 US9314468, Table 7, Compound 90::US9314468, Table 9, Compound 7 C-X-C chemokine receptor type 4 Human 59 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221803&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176557 335960726 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388263 C[C@H]1CN(C[C@@H](C)O1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C33H42N6O2/c1-23-19-38(20-24(2)41-23)31(40)22-39-29-12-4-3-11-26(29)27-14-17-35-28(33(27)39)21-37(18-6-5-15-34)30-13-7-9-25-10-8-16-36-32(25)30/h3-4,8,10-12,14,16-17,23-24,30H,5-7,9,13,15,18-22,34H2,1-2H3/t23-,24+,30-/m0/s1 FWHNJLUNLZEIMP-BBANNHEPSA-N 221804 US9314468, Table 7, Compound 91::US9314468, Table 9, Compound 8 C-X-C chemokine receptor type 4 Human 123 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221804&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176500 335960727 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388264 C(N(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12)c1ccccc1N1CCNCC1 221807 US9314468, Table 7, Compound 94 C-X-C chemokine receptor type 4 Human 3730 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221807&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924238 335960728 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388265 NCCCCN(Cc1nccc2c3ccccc3n(CCCN)c12)[C@H]1CCCc2cccnc12 InChI=1S/C28H36N6/c29-14-3-4-18-33(26-12-5-8-21-9-6-16-32-27(21)26)20-24-28-23(13-17-31-24)22-10-1-2-11-25(22)34(28)19-7-15-30/h1-2,6,9-11,13,16-17,26H,3-5,7-8,12,14-15,18-20,29-30H2/t26-/m0/s1 ANWJCECNNDZVCW-SANMLTNESA-N 221808 US9314468, Table 7, Compound 95::US9314468, Table 9, Compound 9 C-X-C chemokine receptor type 4 Human 21 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221808&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176357 335960729 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388266 NCCCCN(Cc1nccc2c3ccccc3n(Cc3ccncc3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H34N6/c32-15-3-4-20-36(29-11-5-7-24-8-6-16-35-30(24)29)22-27-31-26(14-19-34-27)25-9-1-2-10-28(25)37(31)21-23-12-17-33-18-13-23/h1-2,6,8-10,12-14,16-19,29H,3-5,7,11,15,20-22,32H2/t29-/m0/s1 MWFBWKCYDSLOFC-LJAQVGFWSA-N 221809 US9314468, Table 7, Compound 96 C-X-C chemokine receptor type 4 Human 120 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221809&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176391 335960730 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388267 CC(C)CN(Cc1nccc2c3ccccc3n(CCCN3C(=O)c4ccccc4C3=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C36H37N5O2/c1-24(2)22-39(32-16-7-10-25-11-8-18-38-33(25)32)23-30-34-27(17-19-37-30)26-12-5-6-15-31(26)40(34)20-9-21-41-35(42)28-13-3-4-14-29(28)36(41)43/h3-6,8,11-15,17-19,24,32H,7,9-10,16,20-23H2,1-2H3/t32-/m0/s1 BPGUKRWORCWNBI-YTTGMZPUSA-N 221810 US9314468, Table 7, Compound 97 C-X-C chemokine receptor type 4 Human 6650 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221810&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176368 335960731 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388268 CCN(Cc1nccc2c3ccccc3n(CCCN)c12)[C@H]1CCCc2cccnc12 InChI=1S/C26H31N5/c1-2-30(24-12-5-8-19-9-6-15-29-25(19)24)18-22-26-21(13-16-28-22)20-10-3-4-11-23(20)31(26)17-7-14-27/h3-4,6,9-11,13,15-16,24H,2,5,7-8,12,14,17-18,27H2,1H3/t24-/m0/s1 NOTNDRDNSOJNKN-DEOSSOPVSA-N 221811 US9314468, Table 7, Compound 98 C-X-C chemokine receptor type 4 Human 997 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221811&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176463 335960732 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388269 OC(=O)Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C30H36N6O2/c37-28(38)21-36-26-9-2-1-8-23(26)24-11-13-32-25(30(24)36)20-35(17-5-16-34-18-14-31-15-19-34)27-10-3-6-22-7-4-12-33-29(22)27/h1-2,4,7-9,11-13,27,31H,3,5-6,10,14-21H2,(H,37,38)/t27-/m0/s1 DQIXSGCNKIWJOJ-MHZLTWQESA-N 221813 US9314468, Table 7, Compound 100::US9314468, Table 9, Compound 10 C-X-C chemokine receptor type 4 Human 135 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221813&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176375 335960733 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388270 NCCCCN(Cc1nccc2c3ccccc3n(CCN3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H41N7/c32-13-3-4-18-37(29-11-5-7-24-8-6-14-35-30(24)29)23-27-31-26(12-15-34-27)25-9-1-2-10-28(25)38(31)22-21-36-19-16-33-17-20-36/h1-2,6,8-10,12,14-15,29,33H,3-5,7,11,13,16-23,32H2/t29-/m0/s1 UVLUSKOWWGCJCZ-LJAQVGFWSA-N 221814 US9314468, Table 7, Compound 101::US9314468, Table 9, Compound 11 C-X-C chemokine receptor type 4 Human 63 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221814&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924198 335960734 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388271 NCCCCN(Cc1nccc2c3ccccc3n(Cc3cccnc3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H34N6/c32-15-3-4-19-36(29-13-5-9-24-10-7-17-35-30(24)29)22-27-31-26(14-18-34-27)25-11-1-2-12-28(25)37(31)21-23-8-6-16-33-20-23/h1-2,6-8,10-12,14,16-18,20,29H,3-5,9,13,15,19,21-22,32H2/t29-/m0/s1 XGPPOCYPIPWAOC-LJAQVGFWSA-N 221815 US9314468, Table 7, Compound 102 C-X-C chemokine receptor type 4 Human 481 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221815&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176397 335960735 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388272 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCC(O)CC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H40N6O2/c33-15-3-4-18-37(29-11-5-7-23-8-6-16-35-31(23)29)21-27-32-26(12-17-34-27)25-9-1-2-10-28(25)38(32)22-30(40)36-19-13-24(39)14-20-36/h1-2,6,8-10,12,16-17,24,29,39H,3-5,7,11,13-15,18-22,33H2/t29-/m0/s1 QRHNEAJSJWCSFE-LJAQVGFWSA-N 221816 US9314468, Table 7, Compound 103 C-X-C chemokine receptor type 4 Human 212 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221816&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176517 335960736 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388273 CC(C)(C)OC(=O)[C@@H](N)CCCN(Cc1nccc2c3ccccc3[nH]c12)[C@H]1CCCc2cccnc12 221817 US9314468, Table 7, Compound 104 C-X-C chemokine receptor type 4 Human 9585 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221817&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924094 335960737 C03317 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388274 CN1CCN(CCCN(Cc2nccc3c4ccccc4[nH]c23)[C@H]2CCCc3cccnc23)CC1 221818 US9314468, Table 7, Compound 105 C-X-C chemokine receptor type 4 Human 206 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221818&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924240 335960738 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388275 C(CN(Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12)[C@H]1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C34H45N7O/c1-2-9-31-28(8-1)29-11-13-36-30(34(29)41(31)21-20-39-22-24-42-25-23-39)26-40(17-5-16-38-18-14-35-15-19-38)32-10-3-6-27-7-4-12-37-33(27)32/h1-2,4,7-9,11-13,32,35H,3,5-6,10,14-26H2/t32-/m0/s1 GXPPYEGXOSWLLT-YTTGMZPUSA-N 221819 US9314468, Table 7, Compound 106 C-X-C chemokine receptor type 4 Human 24 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221819&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176516 335960739 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388276 OCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C30H38N6O/c37-21-20-36-27-9-2-1-8-24(27)25-11-13-32-26(30(25)36)22-35(17-5-16-34-18-14-31-15-19-34)28-10-3-6-23-7-4-12-33-29(23)28/h1-2,4,7-9,11-13,28,31,37H,3,5-6,10,14-22H2/t28-/m0/s1 PLCLLBVMKOLHCX-NDEPHWFRSA-N 221820 US9314468, Table 7, Compound 107 C-X-C chemokine receptor type 4 Human 56 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221820&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176449 335960740 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388277 C(N[C@H]1CCCc2cccnc12)c1nccc2c3ccccc3n(Cc3ccccn3)c12 InChI=1S/C27H25N5/c1-2-12-25-21(10-1)22-13-16-29-24(27(22)32(25)18-20-9-3-4-14-28-20)17-31-23-11-5-7-19-8-6-15-30-26(19)23/h1-4,6,8-10,12-16,23,31H,5,7,11,17-18H2/t23-/m0/s1 XVSUSWCJFNERBN-QHCPKHFHSA-N 221821 US9314468, Table 7, Compound 108 C-X-C chemokine receptor type 4 Human 8393 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221821&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176609 335960741 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388278 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCS(=O)CC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H38N6O2S/c32-13-3-4-16-36(28-11-5-7-23-8-6-14-34-30(23)28)21-26-31-25(12-15-33-26)24-9-1-2-10-27(24)37(31)22-29(38)35-17-19-40(39)20-18-35/h1-2,6,8-10,12,14-15,28H,3-5,7,11,13,16-22,32H2/t28-/m0/s1 BOAIQEIFVSEBKI-NDEPHWFRSA-N 221822 US9314468, Table 7, Compound 109 C-X-C chemokine receptor type 4 Human 61 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221822&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176434 335960742 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388279 C(C1CCCNC1)N(Cc1nccc2c1[nH]c1ccccc21)[C@H]1CCCc2cccnc12 221824 US9314468, Table 7, Compound 111 C-X-C chemokine receptor type 4 Human 3597 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221824&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924216 335960743 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388280 NCCCCN(Cc1nccc2c3ccccc3n(CC(N)=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H32N6O/c28-13-3-4-16-32(24-11-5-7-19-8-6-14-31-26(19)24)17-22-27-21(12-15-30-22)20-9-1-2-10-23(20)33(27)18-25(29)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H2,29,34)/t24-/m0/s1 ABDLOXDCMBBRCJ-DEOSSOPVSA-N 221825 US9314468, Table 7, Compound 112::US9314468, Table 9, Compound 14 C-X-C chemokine receptor type 4 Human 17 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221825&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176416 335960744 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388281 C(CN(Cc1nccc2c3ccccc3n(Cc3ccccn3)c12)[C@H]1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C34H39N7/c1-2-12-31-28(11-1)29-14-17-37-30(34(29)41(31)24-27-10-3-4-15-36-27)25-40(21-7-20-39-22-18-35-19-23-39)32-13-5-8-26-9-6-16-38-33(26)32/h1-4,6,9-12,14-17,32,35H,5,7-8,13,18-25H2/t32-/m0/s1 ZNWWVFUMACKVMN-YTTGMZPUSA-N 221826 US9314468, Table 7, Compound 113 C-X-C chemokine receptor type 4 Human 176 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221826&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176597 335960745 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388282 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)NC3CCOCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H40N6O2/c33-15-3-4-18-37(29-11-5-7-23-8-6-16-35-31(23)29)21-27-32-26(12-17-34-27)25-9-1-2-10-28(25)38(32)22-30(39)36-24-13-19-40-20-14-24/h1-2,6,8-10,12,16-17,24,29H,3-5,7,11,13-15,18-22,33H2,(H,36,39)/t29-/m0/s1 QQAXZKBDEDJOOC-LJAQVGFWSA-N 221827 US9314468, Table 7, Compound 114 C-X-C chemokine receptor type 4 Human 21 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221827&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176456 335960746 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388283 O=C(Cn1c2ccccc2c2ccnc(CN(CCCCNCc3ccccn3)[C@H]3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C37H43N7O2/c45-35(42-21-23-46-24-22-42)27-44-33-13-2-1-12-30(33)31-15-19-40-32(37(31)44)26-43(34-14-7-9-28-10-8-18-41-36(28)34)20-6-5-16-38-25-29-11-3-4-17-39-29/h1-4,8,10-13,15,17-19,34,38H,5-7,9,14,16,20-27H2/t34-/m0/s1 PNFIKARXLYHDLX-UMSFTDKQSA-N 221828 US9314468, Table 7, Compound 115 C-X-C chemokine receptor type 4 Human 8650 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221828&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176528 335960747 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388284 CN1CCN(CCCN(Cc2nccc3c4ccccc4n(CC(=O)N4CCOCC4)c23)[C@H]2CCCc3cccnc23)CC1 InChI=1S/C35H45N7O2/c1-38-17-19-39(20-18-38)15-6-16-41(32-11-4-7-27-8-5-13-37-34(27)32)25-30-35-29(12-14-36-30)28-9-2-3-10-31(28)42(35)26-33(43)40-21-23-44-24-22-40/h2-3,5,8-10,12-14,32H,4,6-7,11,15-26H2,1H3/t32-/m0/s1 RKEAONCKABKXHL-YTTGMZPUSA-N 221829 US9314468, Table 7, Compound 116 C-X-C chemokine receptor type 4 Human 628 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221829&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176438 335960748 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388285 O=C(Cn1c2ccccc2c2ccnc(CN(CCCCNCc3cccnc3)[C@H]3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C37H43N7O2/c45-35(42-20-22-46-23-21-42)27-44-33-12-2-1-11-30(33)31-14-18-40-32(37(31)44)26-43(34-13-5-9-29-10-7-17-41-36(29)34)19-4-3-15-38-24-28-8-6-16-39-25-28/h1-2,6-8,10-12,14,16-18,25,34,38H,3-5,9,13,15,19-24,26-27H2/t34-/m0/s1 NCTQNPPLSKQNIC-UMSFTDKQSA-N 221830 US9314468, Table 7, Compound 117 C-X-C chemokine receptor type 4 Human 1398 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221830&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176417 335960749 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388286 O=C(Cn1c2ccccc2c2ccnc(CN(CCCCNCc3ccncc3)[C@H]3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C37H43N7O2/c45-35(42-21-23-46-24-22-42)27-44-33-10-2-1-9-30(33)31-14-19-40-32(37(31)44)26-43(34-11-5-7-29-8-6-16-41-36(29)34)20-4-3-15-39-25-28-12-17-38-18-13-28/h1-2,6,8-10,12-14,16-19,34,39H,3-5,7,11,15,20-27H2/t34-/m0/s1 IFFWGUXVELEIQG-UMSFTDKQSA-N 221831 US9314468, Table 7, Compound 118 C-X-C chemokine receptor type 4 Human 2830 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221831&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176610 335960750 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388287 NCCCCN(Cc1nccc2c3ccccc3n(CCC3CCOCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H41N5O/c33-16-3-4-19-36(30-11-5-7-25-8-6-17-35-31(25)30)23-28-32-27(12-18-34-28)26-9-1-2-10-29(26)37(32)20-13-24-14-21-38-22-15-24/h1-2,6,8-10,12,17-18,24,30H,3-5,7,11,13-16,19-23,33H2/t30-/m0/s1 LZTDOUVCVHNFEM-PMERELPUSA-N 221832 US9314468, Table 7, Compound 119 C-X-C chemokine receptor type 4 Human 13 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221832&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 44242668 335960751 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388288 NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNC(=O)C3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H41N7O/c33-14-3-4-19-38(29-12-5-8-24-9-6-15-36-31(24)29)22-27-32-26(13-16-34-27)25-10-1-2-11-28(25)39(32)20-7-18-37-21-17-35-30(40)23-37/h1-2,6,9-11,13,15-16,29H,3-5,7-8,12,14,17-23,33H2,(H,35,40)/t29-/m0/s1 MBHUJRZOYOOKOG-LJAQVGFWSA-N 221834 US9314468, Table 7, Compound 121 C-X-C chemokine receptor type 4 Human 4 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221834&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176550 335960752 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388289 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCSCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H38N6OS/c32-13-3-4-16-36(28-11-5-7-23-8-6-14-34-30(23)28)21-26-31-25(12-15-33-26)24-9-1-2-10-27(24)37(31)22-29(38)35-17-19-39-20-18-35/h1-2,6,8-10,12,14-15,28H,3-5,7,11,13,16-22,32H2/t28-/m0/s1 DDCLYEJMNJXGRV-NDEPHWFRSA-N 221835 US9314468, Table 7, Compound 122 C-X-C chemokine receptor type 4 Human 78 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221835&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176602 335960753 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388290 NCCCCN(Cc1nccc2c3ccccc3n(Cc3ccccc3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H35N5/c33-18-6-7-21-36(30-16-8-12-25-13-9-19-35-31(25)30)23-28-32-27(17-20-34-28)26-14-4-5-15-29(26)37(32)22-24-10-2-1-3-11-24/h1-5,9-11,13-15,17,19-20,30H,6-8,12,16,18,21-23,33H2/t30-/m0/s1 WEMCGFDUPVQCAC-PMERELPUSA-N 221836 US9314468, Table 7, Compound 123 C-X-C chemokine receptor type 4 Human 47 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221836&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176428 335960754 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388291 O=C(Cn1c2ccccc2c2ccnc(CN(CCCN3CCNC(=O)C3)[C@H]3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C34H41N7O3/c42-31-23-38(17-14-36-31)15-5-16-40(30-10-3-6-25-7-4-12-37-33(25)30)22-28-34-27(11-13-35-28)26-8-1-2-9-29(26)41(34)24-32(43)39-18-20-44-21-19-39/h1-2,4,7-9,11-13,30H,3,5-6,10,14-24H2,(H,36,42)/t30-/m0/s1 JKOGSJOPSZXTMP-PMERELPUSA-N 221839 US9314468, Table 7, Compound 126 C-X-C chemokine receptor type 4 Human 8720 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221839&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176445 335960755 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388292 O=C(Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12)NC1CCOCC1 InChI=1S/C35H45N7O2/c43-33(39-27-12-22-44-23-13-27)25-42-31-9-2-1-8-28(31)29-11-15-37-30(35(29)42)24-41(19-5-18-40-20-16-36-17-21-40)32-10-3-6-26-7-4-14-38-34(26)32/h1-2,4,7-9,11,14-15,27,32,36H,3,5-6,10,12-13,16-25H2,(H,39,43)/t32-/m0/s1 SXOHHHOAPGKUHV-YTTGMZPUSA-N 221840 US9314468, Table 7, Compound 127 C-X-C chemokine receptor type 4 Human 26 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221840&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176485 335960756 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388293 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCCCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H40N6O/c33-16-4-7-21-37(29-14-8-10-24-11-9-17-35-31(24)29)22-27-32-26(15-18-34-27)25-12-2-3-13-28(25)38(32)23-30(39)36-19-5-1-6-20-36/h2-3,9,11-13,15,17-18,29H,1,4-8,10,14,16,19-23,33H2/t29-/m0/s1 QXQQHODCDQBEDT-LJAQVGFWSA-N 221841 US9314468, Table 7, Compound 128 C-X-C chemokine receptor type 4 Human 270 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221841&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176475 335960757 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388294 O=C(Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12)N1CCCCC1 InChI=1S/C35H45N7O/c43-33(40-20-4-1-5-21-40)26-42-31-12-3-2-11-28(31)29-14-16-37-30(35(29)42)25-41(22-8-19-39-23-17-36-18-24-39)32-13-6-9-27-10-7-15-38-34(27)32/h2-3,7,10-12,14-16,32,36H,1,4-6,8-9,13,17-26H2/t32-/m0/s1 HZQYUEGYDCWPKC-YTTGMZPUSA-N 221842 US9314468, Table 7, Compound 129 C-X-C chemokine receptor type 4 Human 405 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221842&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176611 335960758 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388295 C(CN(Cc1nccc2c3ccccc3n(Cc3ccccc3)c12)[C@H]1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C35H40N6/c1-2-9-27(10-3-1)25-41-32-14-5-4-13-29(32)30-16-18-37-31(35(30)41)26-40(22-8-21-39-23-19-36-20-24-39)33-15-6-11-28-12-7-17-38-34(28)33/h1-5,7,9-10,12-14,16-18,33,36H,6,8,11,15,19-26H2/t33-/m0/s1 FISURVXVMMHVJY-XIFFEERXSA-N 221843 US9314468, Table 7, Compound 130 C-X-C chemokine receptor type 4 Human 152 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221843&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176639 335960759 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388296 O=C1N(CCCn2c3ccccc3c3ccnc(CN(CCCN4CCNC(=O)C4)[C@H]4CCCc5cccnc45)c23)C(=O)c2ccccc12 InChI=1S/C39H41N7O3/c47-35-26-43(24-19-41-35)20-7-21-44(34-15-5-9-27-10-6-17-42-36(27)34)25-32-37-29(16-18-40-32)28-11-3-4-14-33(28)45(37)22-8-23-46-38(48)30-12-1-2-13-31(30)39(46)49/h1-4,6,10-14,16-18,34H,5,7-9,15,19-26H2,(H,41,47)/t34-/m0/s1 QJJNRDIHTMEJQU-UMSFTDKQSA-N 221844 US9314468, Table 7, Compound 131 C-X-C chemokine receptor type 4 Human 138 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221844&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176448 335960760 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388297 O=C(Cn1c2ccccc2c2ccnc(CN(CCCC3CCNCC3)[C@H]3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C35H44N6O2/c42-33(39-20-22-43-23-21-39)25-41-31-10-2-1-9-28(31)29-14-18-37-30(35(29)41)24-40(19-5-6-26-12-16-36-17-13-26)32-11-3-7-27-8-4-15-38-34(27)32/h1-2,4,8-10,14-15,18,26,32,36H,3,5-7,11-13,16-17,19-25H2/t32-/m0/s1 DTWYHOJPBDJGOX-YTTGMZPUSA-N 221845 US9314468, Table 7, Compound 132 C-X-C chemokine receptor type 4 Human 124 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221845&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176411 335960761 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388298 Cc1cccnc1CN(CCCCN)Cc1nccc2c3ccccc3n(CC(=O)N3CCOCC3)c12 InChI=1S/C29H36N6O2/c1-22-7-6-12-31-25(22)19-33(14-5-4-11-30)20-26-29-24(10-13-32-26)23-8-2-3-9-27(23)35(29)21-28(36)34-15-17-37-18-16-34/h2-3,6-10,12-13H,4-5,11,14-21,30H2,1H3 TXTDPPRSFZXQSH-UHFFFAOYSA-N 221846 US9314468, Table 7, Compound 133 C-X-C chemokine receptor type 4 Human 583 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221846&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176494 335960762 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388299 O=C1N(CCCn2c3ccccc3c3ccnc(CN(CCCN4CCNCC4)[C@H]4CCCc5cccnc45)c23)C(=O)c2ccccc12 InChI=1S/C39H43N7O2/c47-38-31-12-1-2-13-32(31)39(48)46(38)24-8-23-45-34-14-4-3-11-29(34)30-16-18-41-33(37(30)45)27-44(22-7-21-43-25-19-40-20-26-43)35-15-5-9-28-10-6-17-42-36(28)35/h1-4,6,10-14,16-18,35,40H,5,7-9,15,19-27H2/t35-/m0/s1 KZNPSFOFSKDWBF-DHUJRADRSA-N 221847 US9314468, Table 7, Compound 134 C-X-C chemokine receptor type 4 Human 44 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221847&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176455 335960763 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388300 NCCCn1c2ccccc2c2ccnc(CN(CCCN3CCNC(=O)C3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C31H39N7O/c32-13-5-19-38-27-10-2-1-9-24(27)25-12-15-33-26(31(25)38)21-37(18-6-17-36-20-16-34-29(39)22-36)28-11-3-7-23-8-4-14-35-30(23)28/h1-2,4,8-10,12,14-15,28H,3,5-7,11,13,16-22,32H2,(H,34,39)/t28-/m0/s1 MBBNVMFTQPOESS-NDEPHWFRSA-N 221848 US9314468, Table 7, Compound 135 C-X-C chemokine receptor type 4 Human 30 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221848&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176413 335960764 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388301 N[C@H]1CC[C@H](CN(Cc2nccc3c4ccccc4n(CC(=O)N4CCOCC4)c23)[C@H]2CCCc3cccnc23)CC1 InChI=1S/C34H42N6O2/c35-26-12-10-24(11-13-26)21-39(31-9-3-5-25-6-4-15-37-33(25)31)22-29-34-28(14-16-36-29)27-7-1-2-8-30(27)40(34)23-32(41)38-17-19-42-20-18-38/h1-2,4,6-8,14-16,24,26,31H,3,5,9-13,17-23,35H2/t24-,26-,31-/m0/s1 YFGRYLFTDBFCPF-NLVXVLGSSA-N 221849 US9314468, Table 7, Compound 136 C-X-C chemokine receptor type 4 Human 2150 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221849&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176401 335960765 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388302 N[C@H]1CC[C@@H](CN(Cc2nccc3c4ccccc4n(CC(=O)N4CCOCC4)c23)[C@H]2CCCc3cccnc23)CC1 InChI=1S/C34H42N6O2/c35-26-12-10-24(11-13-26)21-39(31-9-3-5-25-6-4-15-37-33(25)31)22-29-34-28(14-16-36-29)27-7-1-2-8-30(27)40(34)23-32(41)38-17-19-42-20-18-38/h1-2,4,6-8,14-16,24,26,31H,3,5,9-13,17-23,35H2/t24-,26+,31-/m0/s1 YFGRYLFTDBFCPF-DHUXRJIASA-N 221850 US9314468, Table 7, Compound 137 C-X-C chemokine receptor type 4 Human 1260 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221850&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176401 335960766 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388303 NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNCC3=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H41N7O/c33-14-3-4-18-38(29-12-5-8-24-9-6-15-36-31(24)29)23-27-32-26(13-16-35-27)25-10-1-2-11-28(25)39(32)20-7-19-37-21-17-34-22-30(37)40/h1-2,6,9-11,13,15-16,29,34H,3-5,7-8,12,14,17-23,33H2/t29-/m0/s1 RENOYQQZOIIFJP-LJAQVGFWSA-N 221851 US9314468, Table 7, Compound 138 C-X-C chemokine receptor type 4 Human 20 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221851&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176436 335960767 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388304 O=C1CNCCN1CCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C35H46N8O/c44-33-25-37-17-24-41(33)19-6-21-43-31-10-2-1-9-28(31)29-12-14-38-30(35(29)43)26-42(20-5-18-40-22-15-36-16-23-40)32-11-3-7-27-8-4-13-39-34(27)32/h1-2,4,8-10,12-14,32,36-37H,3,5-7,11,15-26H2/t32-/m0/s1 DSSMQNFSKOOFIX-YTTGMZPUSA-N 221852 US9314468, Table 7, Compound 139 C-X-C chemokine receptor type 4 Human 44 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221852&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176442 335960768 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388305 NC(=O)Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C30H37N7O/c31-28(38)21-37-26-9-2-1-8-23(26)24-11-13-33-25(30(24)37)20-36(17-5-16-35-18-14-32-15-19-35)27-10-3-6-22-7-4-12-34-29(22)27/h1-2,4,7-9,11-13,27,32H,3,5-6,10,14-21H2,(H2,31,38)/t27-/m0/s1 KSQLGAFWFIKFHD-MHZLTWQESA-N 221853 US9314468, Table 7, Compound 140 C-X-C chemokine receptor type 4 Human 9 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221853&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176472 335960769 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388306 NCCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C31H41N7/c32-13-5-20-38-28-10-2-1-9-25(28)26-12-15-34-27(31(26)38)23-37(19-6-18-36-21-16-33-17-22-36)29-11-3-7-24-8-4-14-35-30(24)29/h1-2,4,8-10,12,14-15,29,33H,3,5-7,11,13,16-23,32H2/t29-/m0/s1 NHAJVACWMBMLAO-LJAQVGFWSA-N 221854 US9314468, Table 7, Compound 141 C-X-C chemokine receptor type 4 Human 5 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221854&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176450 335960770 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388307 COCCn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C28H35N5O/c1-34-19-18-33-25-11-3-2-10-22(25)23-13-16-30-24(28(23)33)20-32(17-5-4-14-29)26-12-6-8-21-9-7-15-31-27(21)26/h2-3,7,9-11,13,15-16,26H,4-6,8,12,14,17-20,29H2,1H3/t26-/m0/s1 WUOCTJUKAZEITD-SANMLTNESA-N 221856 US9314468, Table 7, Compound 143 C-X-C chemokine receptor type 4 Human 20 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221856&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176569 335960771 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388308 NCCCCN(Cc1nccc2c3ccccc3n(CC3CC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C29H35N5/c30-15-3-4-18-33(27-11-5-7-22-8-6-16-32-28(22)27)20-25-29-24(14-17-31-25)23-9-1-2-10-26(23)34(29)19-21-12-13-21/h1-2,6,8-10,14,16-17,21,27H,3-5,7,11-13,15,18-20,30H2/t27-/m0/s1 JWEASISYMFSBIV-MHZLTWQESA-N 221857 US9314468, Table 7, Compound 144 C-X-C chemokine receptor type 4 Human 4 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221857&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176621 335960772 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388309 C(CN(Cc1nccc2c3ccccc3n(CC3CC3)c12)[C@H]1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C32H40N6/c1-2-9-29-26(8-1)27-13-15-34-28(32(27)38(29)22-24-11-12-24)23-37(19-5-18-36-20-16-33-17-21-36)30-10-3-6-25-7-4-14-35-31(25)30/h1-2,4,7-9,13-15,24,30,33H,3,5-6,10-12,16-23H2/t30-/m0/s1 QPNBBISYSKBKRT-PMERELPUSA-N 221858 US9314468, Table 7, Compound 145 C-X-C chemokine receptor type 4 Human 14 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221858&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176387 335960773 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388310 COCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C31H40N6O/c1-38-22-21-37-28-10-3-2-9-25(28)26-12-14-33-27(31(26)37)23-36(18-6-17-35-19-15-32-16-20-35)29-11-4-7-24-8-5-13-34-30(24)29/h2-3,5,8-10,12-14,29,32H,4,6-7,11,15-23H2,1H3/t29-/m0/s1 HBVFWULQULOZOQ-LJAQVGFWSA-N 221859 US9314468, Table 7, Compound 146 C-X-C chemokine receptor type 4 Human 49 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221859&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176467 335960774 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388311 C(CN(Cc1nccc2c3ccccc3n(CCC3CCOCC3)c12)[C@H]1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C35H46N6O/c1-2-9-32-29(8-1)30-11-16-37-31(35(30)41(32)21-12-27-13-24-42-25-14-27)26-40(20-5-19-39-22-17-36-18-23-39)33-10-3-6-28-7-4-15-38-34(28)33/h1-2,4,7-9,11,15-16,27,33,36H,3,5-6,10,12-14,17-26H2/t33-/m0/s1 IBIHADAFGHQXNB-XIFFEERXSA-N 221860 US9314468, Table 7, Compound 147 C-X-C chemokine receptor type 4 Human 1 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221860&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176553 335960775 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388312 CC(N(CCCCN)Cc1nccc2c3ccccc3n(CC(=O)N3CCOCC3)c12)c1ccccn1 InChI=1S/C29H36N6O2/c1-22(25-9-4-6-13-31-25)34(15-7-5-12-30)20-26-29-24(11-14-32-26)23-8-2-3-10-27(23)35(29)21-28(36)33-16-18-37-19-17-33/h2-4,6,8-11,13-14,22H,5,7,12,15-21,30H2,1H3 GIFQJTINYJNXAQ-UHFFFAOYSA-N 221862 US9314468, Table 7, Compound 149 C-X-C chemokine receptor type 4 Human 423 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221862&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176414 335960776 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388313 NCCCCN(Cc1nccc2c3ccccc3n(CCN3CCNCC3)c12)C1CCCc2cccnc12 InChI=1S/C31H41N7/c32-13-3-4-18-37(29-11-5-7-24-8-6-14-35-30(24)29)23-27-31-26(12-15-34-27)25-9-1-2-10-28(25)38(31)22-21-36-19-16-33-17-20-36/h1-2,6,8-10,12,14-15,29,33H,3-5,7,11,13,16-23,32H2 UVLUSKOWWGCJCZ-UHFFFAOYSA-N 221863 US9314468, Table 8, Compound 1 C-X-C chemokine receptor type 4 Human 5.7 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221863&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 77955572 335960777 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388314 NCCCCN(Cc1nccc2c3ccccc3n(CC#C)c12)C1CCCc2cccnc12 InChI=1S/C28H31N5/c1-2-18-33-25-12-4-3-11-22(25)23-14-17-30-24(28(23)33)20-32(19-6-5-15-29)26-13-7-9-21-10-8-16-31-27(21)26/h1,3-4,8,10-12,14,16-17,26H,5-7,9,13,15,18-20,29H2 LWLCPNMLRWYQTO-UHFFFAOYSA-N 221864 US9314468, Table 8, Compound 2 C-X-C chemokine receptor type 4 Human 5.5 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221864&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535523 335960778 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388315 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCOCC3)c12)C1CCCc2cccnc12 InChI=1S/C31H38N6O2/c32-13-3-4-16-36(28-11-5-7-23-8-6-14-34-30(23)28)21-26-31-25(12-15-33-26)24-9-1-2-10-27(24)37(31)22-29(38)35-17-19-39-20-18-35/h1-2,6,8-10,12,14-15,28H,3-5,7,11,13,16-22,32H2 PBOCFANSMNVTHY-UHFFFAOYSA-N 221865 US9314468, Table 8, Compound 3 C-X-C chemokine receptor type 4 Human 5.6 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221865&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 68791630 335960779 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388316 NCCCCN(Cc1nccc2c3ccccc3n(CC(N)=O)c12)C1CCCc2cccnc12 InChI=1S/C27H32N6O/c28-13-3-4-16-32(24-11-5-7-19-8-6-14-31-26(19)24)17-22-27-21(12-15-30-22)20-9-1-2-10-23(20)33(27)18-25(29)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H2,29,34) ABDLOXDCMBBRCJ-UHFFFAOYSA-N 221866 US9314468, Table 8, Compound 4 C-X-C chemokine receptor type 4 Human 5.8 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221866&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535462 335960780 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388317 NCCCCN(Cc1nccc2c3ccccc3n(CCCN)c12)C1CCCc2cccnc12 InChI=1S/C28H36N6/c29-14-3-4-18-33(26-12-5-8-21-9-6-16-32-27(21)26)20-24-28-23(13-17-31-24)22-10-1-2-11-25(22)34(28)19-7-15-30/h1-2,6,9-11,13,16-17,26H,3-5,7-8,12,14-15,18-20,29-30H2 ANWJCECNNDZVCW-UHFFFAOYSA-N 221867 US9314468, Table 8, Compound 5 C-X-C chemokine receptor type 4 Human 7.3 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221867&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535437 335960781 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388318 NCCCCN(Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12)C1CCCc2cccnc12 InChI=1S/C31H40N6O/c32-13-3-4-16-36(29-11-5-7-24-8-6-14-34-30(24)29)23-27-31-26(12-15-33-27)25-9-1-2-10-28(25)37(31)18-17-35-19-21-38-22-20-35/h1-2,6,8-10,12,14-15,29H,3-5,7,11,13,16-23,32H2 CVDHYOXZYVHTOU-UHFFFAOYSA-N 221868 US9314468, Table 8, Compound 6 C-X-C chemokine receptor type 4 Human 7.7 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221868&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535445 335960782 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388319 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)[I]=O)c12)C1CCCc2cccnc12 InChI=1S/C27H30IN5O2/c29-13-3-4-16-32(24-11-5-7-19-8-6-14-31-26(19)24)17-22-27-21(12-15-30-22)20-9-1-2-10-23(20)33(27)18-25(34)28-35/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,29H2 MNAZTJAVYQATRR-UHFFFAOYSA-N 221869 US9314468, Table 8, Compound 7 C-X-C chemokine receptor type 4 Human 8.1 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221869&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 126842508 335960783 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388320 NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNCC3)c12)C1CCCc2cccnc12 InChI=1S/C32H43N7/c33-14-3-4-20-38(30-12-5-8-25-9-6-15-36-31(25)30)24-28-32-27(13-16-35-28)26-10-1-2-11-29(26)39(32)21-7-19-37-22-17-34-18-23-37/h1-2,6,9-11,13,15-16,30,34H,3-5,7-8,12,14,17-24,33H2 KRDNCRHWZIFVKV-UHFFFAOYSA-N 221870 US9314468, Table 8, Compound 8 C-X-C chemokine receptor type 4 Human 8.3 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221870&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535503 335960784 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388321 C(CN(Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12)C1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C34H45N7O/c1-2-9-31-28(8-1)29-11-13-36-30(34(29)41(31)21-20-39-22-24-42-25-23-39)26-40(17-5-16-38-18-14-35-15-19-38)32-10-3-6-27-7-4-12-37-33(27)32/h1-2,4,7-9,11-13,32,35H,3,5-6,10,14-26H2 GXPPYEGXOSWLLT-UHFFFAOYSA-N 221871 US9314468, Table 8, Compound 9::US9314468, Table 9, Compound 12 C-X-C chemokine receptor type 4 Human 9.3 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221871&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70965023 335960785 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388322 C[C@H]1CN(C[C@@H](C)O1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)C3CCCc4cccnc34)c12 InChI=1S/C33H42N6O2/c1-23-19-38(20-24(2)41-23)31(40)22-39-29-12-4-3-11-26(29)27-14-17-35-28(33(27)39)21-37(18-6-5-15-34)30-13-7-9-25-10-8-16-36-32(25)30/h3-4,8,10-12,14,16-17,23-24,30H,5-7,9,13,15,18-22,34H2,1-2H3/t23-,24+,30? FWHNJLUNLZEIMP-QBONCRILSA-N 221872 US9314468, Table 8, Compound 10 C-X-C chemokine receptor type 4 Human 9.9 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221872&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 89667385 335960786 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388323 CN1CCN(CC1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)C3CCCc4cccnc34)c12 InChI=1S/C32H41N7O/c1-36-18-20-37(21-19-36)30(40)23-39-28-11-3-2-10-25(28)26-13-16-34-27(32(26)39)22-38(17-5-4-14-33)29-12-6-8-24-9-7-15-35-31(24)29/h2-3,7,9-11,13,15-16,29H,4-6,8,12,14,17-23,33H2,1H3 JQTHZRINXVEAFM-UHFFFAOYSA-N 221873 US9314468, Table 8, Compound 11 C-X-C chemokine receptor type 4 Human 11 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221873&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535488 335960787 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388324 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)NC3CCNCC3)c12)C1CCCc2cccnc12 InChI=1S/C32H41N7O/c33-15-3-4-20-38(29-11-5-7-23-8-6-16-36-31(23)29)21-27-32-26(14-19-35-27)25-9-1-2-10-28(25)39(32)22-30(40)37-24-12-17-34-18-13-24/h1-2,6,8-10,14,16,19,24,29,34H,3-5,7,11-13,15,17-18,20-22,33H2,(H,37,40) OIRFPCPZHQDIOS-UHFFFAOYSA-N 221874 US9314468, Table 8, Compound 12::US9314468, Table 9, Compound 3 C-X-C chemokine receptor type 4 Human 12 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221874&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535470 335960788 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388325 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCC(O)CC3)c12)C1CCCc2cccnc12 InChI=1S/C32H40N6O2/c33-15-3-4-18-37(29-11-5-7-23-8-6-16-35-31(23)29)21-27-32-26(12-17-34-27)25-9-1-2-10-28(25)38(32)22-30(40)36-19-13-24(39)14-20-36/h1-2,6,8-10,12,16-17,24,29,39H,3-5,7,11,13-15,18-22,33H2 QRHNEAJSJWCSFE-UHFFFAOYSA-N 221875 US9314468, Table 8, Compound 13 C-X-C chemokine receptor type 4 Human 12 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221875&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535506 335960789 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388326 OCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)C3CCCc4cccnc34)c12 InChI=1S/C30H38N6O/c37-21-20-36-27-9-2-1-8-24(27)25-11-13-32-26(30(25)36)22-35(17-5-16-34-18-14-31-15-19-34)28-10-3-6-23-7-4-12-33-29(23)28/h1-2,4,7-9,11-13,28,31,37H,3,5-6,10,14-22H2 PLCLLBVMKOLHCX-UHFFFAOYSA-N 221876 US9314468, Table 8, Compound 14::US9314468, Table 9, Compound 13 C-X-C chemokine receptor type 4 Human 12 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221876&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535480 335960790 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388327 O=C(Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)C3CCCc4cccnc34)c12)N1CCOCC1 InChI=1S/C34H43N7O2/c42-32(39-20-22-43-23-21-39)25-41-30-9-2-1-8-27(30)28-11-13-36-29(34(28)41)24-40(17-5-16-38-18-14-35-15-19-38)31-10-3-6-26-7-4-12-37-33(26)31/h1-2,4,7-9,11-13,31,35H,3,5-6,10,14-25H2 KHUKENRHVPYVIS-UHFFFAOYSA-N 221877 US9314468, Table 8, Compound 15 C-X-C chemokine receptor type 4 Human 15 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221877&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 68730442 335960791 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388328 OC(=O)Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)C3CCCc4cccnc34)c12 InChI=1S/C30H36N6O2/c37-28(38)21-36-26-9-2-1-8-23(26)24-11-13-32-25(30(24)36)20-35(17-5-16-34-18-14-31-15-19-34)27-10-3-6-22-7-4-12-33-29(22)27/h1-2,4,7-9,11-13,27,31H,3,5-6,10,14-21H2,(H,37,38) DQIXSGCNKIWJOJ-UHFFFAOYSA-N 221878 US9314468, Table 8, Compound 16 C-X-C chemokine receptor type 4 Human 26 US Patent 10.7270/Q2DF6Q2P aid1802564 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221878&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535446 335960792 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388329 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)N3CCOCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H38N6O2/c32-13-3-4-16-36(28-11-5-7-23-8-6-14-34-30(23)28)21-26-31-25(12-15-33-26)24-9-1-2-10-27(24)37(31)22-29(38)35-17-19-39-20-18-35/h1-2,6,8-10,12,14-15,28H,3-5,7,11,13,16-22,32H2/t28-/m0/s1 PBOCFANSMNVTHY-NDEPHWFRSA-N 221761 US9314468, Table 7, Compound 48::US9314468, Table 9, Compound 1 C-X-C chemokine receptor type 4 Human 12 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221761&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176381 335960697 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388330 NCCCCN(Cc1nccc2c3ccccc3n(CC(O)=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H31N5O2/c28-13-3-4-16-31(24-11-5-7-19-8-6-14-30-26(19)24)17-22-27-21(12-15-29-22)20-9-1-2-10-23(20)32(27)18-25(33)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H,33,34)/t24-/m0/s1 HXSKVZXRXQFNGG-DEOSSOPVSA-N 221769 US9314468, Table 7, Compound 56::US9314468, Table 9, Compound 2 C-X-C chemokine receptor type 4 Human 22 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221769&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176365 335960702 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388331 NCCCCN(Cc1nccc2c3ccccc3n(CC(=O)NC3CCNCC3)c12)C1CCCc2cccnc12 InChI=1S/C32H41N7O/c33-15-3-4-20-38(29-11-5-7-23-8-6-16-36-31(23)29)21-27-32-26(14-19-35-27)25-9-1-2-10-28(25)39(32)22-30(40)37-24-12-17-34-18-13-24/h1-2,6,8-10,14,16,19,24,29,34H,3-5,7,11-13,15,17-18,20-22,33H2,(H,37,40) OIRFPCPZHQDIOS-UHFFFAOYSA-N 221874 US9314468, Table 8, Compound 12::US9314468, Table 9, Compound 3 C-X-C chemokine receptor type 4 Human 126 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221874&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535470 335960788 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388332 NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H43N7/c33-14-3-4-20-38(30-12-5-8-25-9-6-15-36-31(25)30)24-28-32-27(13-16-35-28)26-10-1-2-11-29(26)39(32)21-7-19-37-22-17-34-18-23-37/h1-2,6,9-11,13,15-16,30,34H,3-5,7-8,12,14,17-24,33H2/t30-/m0/s1 KRDNCRHWZIFVKV-PMERELPUSA-N 221783 US9314468, Table 7, Compound 70::US9314468, Table 9, Compound 4 C-X-C chemokine receptor type 4 Human 16 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221783&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176504 335960710 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388333 CN1CCN(CC1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C32H41N7O/c1-36-18-20-37(21-19-36)30(40)23-39-28-11-3-2-10-25(28)26-13-16-34-27(32(26)39)22-38(17-5-4-14-33)29-12-6-8-24-9-7-15-35-31(24)29/h2-3,7,9-11,13,15-16,29H,4-6,8,12,14,17-23,33H2,1H3/t29-/m0/s1 JQTHZRINXVEAFM-LJAQVGFWSA-N 221785 US9314468, Table 7, Compound 72::US9314468, Table 9, Compound 5 C-X-C chemokine receptor type 4 Human 30 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221785&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176465 335960711 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388334 O=C(Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12)C1CCOCC1 InChI=1S/C35H44N6O2/c42-33(26-12-22-43-23-13-26)25-41-31-9-2-1-8-28(31)29-11-15-37-30(35(29)41)24-40(19-5-18-39-20-16-36-17-21-39)32-10-3-6-27-7-4-14-38-34(27)32/h1-2,4,7-9,11,14-15,26,32,36H,3,5-6,10,12-13,16-25H2/t32-/m0/s1 KSUXJPSRDWREHP-YTTGMZPUSA-N 221884 US9314468, Table 9, Compound 6 C-X-C chemokine receptor type 4 Human 44 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221884&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 89667390 335960793 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388335 CC(C)(C)OC(=O)Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C34H44N6O2/c1-34(2,3)42-31(41)24-40-29-12-5-4-11-26(29)27-14-16-36-28(33(27)40)23-39(20-8-19-38-21-17-35-18-22-38)30-13-6-9-25-10-7-15-37-32(25)30/h4-5,7,10-12,14-16,30,35H,6,8-9,13,17-24H2,1-3H3/t30-/m0/s1 AQKCUDVGYZOCIQ-PMERELPUSA-N 221803 US9314468, Table 7, Compound 90::US9314468, Table 9, Compound 7 C-X-C chemokine receptor type 4 Human 37 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221803&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176557 335960726 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388336 C[C@H]1CN(C[C@@H](C)O1)C(=O)Cn1c2ccccc2c2ccnc(CN(CCCCN)[C@H]3CCCc4cccnc34)c12 InChI=1S/C33H42N6O2/c1-23-19-38(20-24(2)41-23)31(40)22-39-29-12-4-3-11-26(29)27-14-17-35-28(33(27)39)21-37(18-6-5-15-34)30-13-7-9-25-10-8-16-36-32(25)30/h3-4,8,10-12,14,16-17,23-24,30H,5-7,9,13,15,18-22,34H2,1-2H3/t23-,24+,30-/m0/s1 FWHNJLUNLZEIMP-BBANNHEPSA-N 221804 US9314468, Table 7, Compound 91::US9314468, Table 9, Compound 8 C-X-C chemokine receptor type 4 Human 123 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221804&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176500 335960727 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388337 NCCCCN(Cc1nccc2c3ccccc3n(CCCN)c12)[C@H]1CCCc2cccnc12 InChI=1S/C28H36N6/c29-14-3-4-18-33(26-12-5-8-21-9-6-16-32-27(21)26)20-24-28-23(13-17-31-24)22-10-1-2-11-25(22)34(28)19-7-15-30/h1-2,6,9-11,13,16-17,26H,3-5,7-8,12,14-15,18-20,29-30H2/t26-/m0/s1 ANWJCECNNDZVCW-SANMLTNESA-N 221808 US9314468, Table 7, Compound 95::US9314468, Table 9, Compound 9 C-X-C chemokine receptor type 4 Human 7 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221808&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176357 335960729 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388338 OC(=O)Cn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)[C@H]3CCCc4cccnc34)c12 InChI=1S/C30H36N6O2/c37-28(38)21-36-26-9-2-1-8-23(26)24-11-13-32-25(30(24)36)20-35(17-5-16-34-18-14-31-15-19-34)27-10-3-6-22-7-4-12-33-29(22)27/h1-2,4,7-9,11-13,27,31H,3,5-6,10,14-21H2,(H,37,38)/t27-/m0/s1 DQIXSGCNKIWJOJ-MHZLTWQESA-N 221813 US9314468, Table 7, Compound 100::US9314468, Table 9, Compound 10 C-X-C chemokine receptor type 4 Human 113 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221813&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176375 335960733 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388339 NCCCCN(Cc1nccc2c3ccccc3n(CCN3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C31H41N7/c32-13-3-4-18-37(29-11-5-7-24-8-6-14-35-30(24)29)23-27-31-26(12-15-34-27)25-9-1-2-10-28(25)38(31)22-21-36-19-16-33-17-20-36/h1-2,6,8-10,12,14-15,29,33H,3-5,7,11,13,16-23,32H2/t29-/m0/s1 UVLUSKOWWGCJCZ-LJAQVGFWSA-N 221814 US9314468, Table 7, Compound 101::US9314468, Table 9, Compound 11 C-X-C chemokine receptor type 4 Human 55 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221814&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70924198 335960734 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388340 C(CN(Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12)C1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C34H45N7O/c1-2-9-31-28(8-1)29-11-13-36-30(34(29)41(31)21-20-39-22-24-42-25-23-39)26-40(17-5-16-38-18-14-35-15-19-38)32-10-3-6-27-7-4-12-37-33(27)32/h1-2,4,7-9,11-13,32,35H,3,5-6,10,14-26H2 GXPPYEGXOSWLLT-UHFFFAOYSA-N 221871 US9314468, Table 8, Compound 9::US9314468, Table 9, Compound 12 C-X-C chemokine receptor type 4 Human 24 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221871&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 70965023 335960785 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388341 OCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)C3CCCc4cccnc34)c12 InChI=1S/C30H38N6O/c37-21-20-36-27-9-2-1-8-24(27)25-11-13-32-26(30(25)36)22-35(17-5-16-34-18-14-31-15-19-34)28-10-3-6-23-7-4-12-33-29(23)28/h1-2,4,7-9,11-13,28,31,37H,3,5-6,10,14-22H2 PLCLLBVMKOLHCX-UHFFFAOYSA-N 221876 US9314468, Table 8, Compound 14::US9314468, Table 9, Compound 13 C-X-C chemokine receptor type 4 Human 56 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221876&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 72535480 335960790 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388342 NCCCCN(Cc1nccc2c3ccccc3n(CC(N)=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H32N6O/c28-13-3-4-16-32(24-11-5-7-19-8-6-14-31-26(19)24)17-22-27-21(12-15-30-22)20-9-1-2-10-23(20)33(27)18-25(29)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H2,29,34)/t24-/m0/s1 ABDLOXDCMBBRCJ-DEOSSOPVSA-N 221825 US9314468, Table 7, Compound 112::US9314468, Table 9, Compound 14 C-X-C chemokine receptor type 4 Human 18 37.00 C US Patent 10.7270/Q2DF6Q2P aid1802563 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9308&target=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221825&enzyme=C-X-C+chemokine+receptor+type+4&column=ki&startPg=0&Increment=50&submit=Search 59176416 335960744 1 MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS C-X-C chemokine receptor type 4 CXCR4_HUMAN P61073 B2R5N0 O60835 P30991 P56438 Q53S69 Q9BXA0 Q9UKN2 388343 NCCCCN(Cc1nccc2c3ccccc3n(CC(O)=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H31N5O2/c28-13-3-4-16-31(24-11-5-7-19-8-6-14-30-26(19)24)17-22-27-21(12-15-29-22)20-9-1-2-10-23(20)32(27)18-25(33)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H,33,34)/t24-/m0/s1 HXSKVZXRXQFNGG-DEOSSOPVSA-N 221769 US9314468, Table 7, Compound 56::US9314468, Table 9, Compound 2 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2700 25.00 C US Patent 10.7270/Q2DF6Q2P aid1802565 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221769&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 59176365 335960702 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 388344 NCCCCN(Cc1nccc2c3ccccc3n(CCCN3CCNCC3)c12)[C@H]1CCCc2cccnc12 InChI=1S/C32H43N7/c33-14-3-4-20-38(30-12-5-8-25-9-6-15-36-31(25)30)24-28-32-27(13-16-35-28)26-10-1-2-11-29(26)39(32)21-7-19-37-22-17-34-18-23-37/h1-2,6,9-11,13,15-16,30,34H,3-5,7-8,12,14,17-24,33H2/t30-/m0/s1 KRDNCRHWZIFVKV-PMERELPUSA-N 221783 US9314468, Table 7, Compound 70::US9314468, Table 9, Compound 4 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4100 25.00 C US Patent 10.7270/Q2DF6Q2P aid1802565 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221783&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 59176504 335960710 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 388345 C(CN(Cc1nccc2c3ccccc3n(CCN3CCOCC3)c12)C1CCCc2cccnc12)CN1CCNCC1 InChI=1S/C34H45N7O/c1-2-9-31-28(8-1)29-11-13-36-30(34(29)41(31)21-20-39-22-24-42-25-23-39)26-40(17-5-16-38-18-14-35-15-19-38)32-10-3-6-27-7-4-12-37-33(27)32/h1-2,4,7-9,11-13,32,35H,3,5-6,10,14-26H2 GXPPYEGXOSWLLT-UHFFFAOYSA-N 221871 US9314468, Table 8, Compound 9::US9314468, Table 9, Compound 12 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3100 25.00 C US Patent 10.7270/Q2DF6Q2P aid1802565 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221871&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 70965023 335960785 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 388346 OCCn1c2ccccc2c2ccnc(CN(CCCN3CCNCC3)C3CCCc4cccnc34)c12 InChI=1S/C30H38N6O/c37-21-20-36-27-9-2-1-8-24(27)25-11-13-32-26(30(25)36)22-35(17-5-16-34-18-14-31-15-19-34)28-10-3-6-23-7-4-12-33-29(23)28/h1-2,4,7-9,11-13,28,31,37H,3,5-6,10,14-22H2 PLCLLBVMKOLHCX-UHFFFAOYSA-N 221876 US9314468, Table 8, Compound 14::US9314468, Table 9, Compound 13 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2400 25.00 C US Patent 10.7270/Q2DF6Q2P aid1802565 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221876&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 72535480 335960790 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 388347 NCCCCN(Cc1nccc2c3ccccc3n(CC(N)=O)c12)[C@H]1CCCc2cccnc12 InChI=1S/C27H32N6O/c28-13-3-4-16-32(24-11-5-7-19-8-6-14-31-26(19)24)17-22-27-21(12-15-30-22)20-9-1-2-10-23(20)33(27)18-25(29)34/h1-2,6,8-10,12,14-15,24H,3-5,7,11,13,16-18,28H2,(H2,29,34)/t24-/m0/s1 ABDLOXDCMBBRCJ-DEOSSOPVSA-N 221825 US9314468, Table 7, Compound 112::US9314468, Table 9, Compound 14 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1800 25.00 C US Patent 10.7270/Q2DF6Q2P aid1802565 US9314468 Clark, MP; Wagner, FF; Natchus, MG; Doroh, BC; Johnson, TL; Tahirovic, YA; Wilson, L; Wiseman, JM; Skudlarek, JW; Lockwood, MA 4/19/2016 4/10/2017 Altiris Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=221825&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 59176416 335960744 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0